Long-Term Neurodevelopmental Outcomes of Children with Congenital Heart Defects

• Published in: The Journal of pediatrics 2021-10, Vol.237, p.109-114.e5
• Main Authors: Derridj, Neil, Guedj, Romain, Calderon, Johanna, Houyel, Lucile, Lelong, Nathalie, Bertille, Nathalie, Goffinet, Francois, Bonnet, Damien, Khoshnood, Babak
• Format: Article
• Language: English
• Subjects: brain; CHD; cyanosis; executive function; heart failure; NEPSY-II
• ISSN: 0022-3476; 1097-6833
• DOI: 10.1016/j.jpeds.2021.06.032

To assess whether children with symptomatic congenital heart defects (CHDs) at birth (cyanosis and/or heart failure) are at greater risk of adverse neurodevelopmental outcomes at 8 years of age. From a prospective population-based cohort study of newborns with CHDs (EPICARD), we included 473 children with available neurodevelopmental assessments at 8 years of age. We grouped the CHD based on symptoms at birth and need for early neonatal intervention. Ventricular septal defects that closed spontaneously within the first year of life were considered the control group. Neurodevelopmental outcomes were assessed using the Kauffman Assessment Battery Test for Children, Second Edition, for IQ (mean 100 ± 15), and the Developmental NEuroPSYchological Assessment Battery, Second Edition, for detailed assessment of specific neurocognitive domains (mean 10 ± 3). Multivariable regression analysis was used to compare the outcomes across the CHD groups after considering potentially confounding variables. Compared with the control group, children with cyanotic CHD without heart failure had lower scores for IQ, −7.2 (95% CI –13.4 to −1.2). Children with noncyanotic CHD with heart failure had lower scores in the specific domains of language −1.5 (95% CI –2.2 to −0.7), and memory and learning −1.3 (95% CI –2.4; −0.3). Those with both cyanotic CHD and heart failure had lower scores for IQ, −7.6 (95% CI –13.5 to −1.8), as well as the specific domains of language and memory and learning, −2.0 (95% CI –2.9 to −1.0) and −1.1 (95% CI –2.3 to −0.1), respectively. Children with symptomatic CHD at birth are at greater risk of adverse neurodevelopmental outcomes at 8 years of age, with the greatest risk for those who were born with both cyanosis and heart failure.